Press Release

<< Back
Printer Friendly Version View printer-friendly version
Depomed to Participate at the Annual Piper Jaffray Healthcare Conference

NEWARK, Calif., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that senior management will participate in a fireside chat at the 29th Annual Piper Jaffray Healthcare Conference at 8:30 am ET (5:30 am PT) on Tuesday, November 28, 2017 in New York, New York. 

The fireside chat will be webcast live and may be accessed via the Investor Relations page of the Depomed website at www.depomed.com.  A recording of this event will be archived for 30 days on the Company's website.

About Depomed

Depomed is a leading specialty pharmaceutical company focused on enhancing the lives of the patients, families, physicians, providers and payors we serve through commercializing innovative products for pain and neurology related disorders. Depomed markets five medicines with areas of focus that include mild to severe acute pain, moderate to severe chronic pain, neuropathic pain and migraine. Depomed is headquartered in Newark, California. To learn more about Depomed, visit www.depomed.com.

Investor Contact:

Christopher Keenan
VP, Investor Relations and Corporate Communications
510-744-8000
ckeenan@depomed.com

Primary Logo

Depomed, Inc.